Global Liver Disease Diagnostics Market By End User (Hospitals, Laboratories and Other End Users), By Diagnosis Technique (Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques), By Region, Industry Analysis and Forecast, 2020 - 2026
The Global Liver Disease Diagnostics Market size is expected to reach $40.7 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. The liver is a vital organ that primarily functions to metabolize and detoxify toxic substances that may be harmful to the body. Liver disease refers to any illness that induces inflammation of the liver and may interfere with the proper functioning of the liver. The causes of liver disease include infection, autoimmune disorders, excessive-intake of drugs, injury, alcohol consumption, among others.
Liver diseases impact millions of people all over the world. In most developing nations, the prevalence of viral hepatitis is increasing as a result of modern advances in disease prevention, diagnosis, and treatment. Extended programs for systematic vaccination against the hepatitis B virus have also significantly reduced the number of new cases in many countries.
On the contrary, with better living conditions, the prevalence of the chronic liver disease, including non-alcoholic fatty liver disease and alcohol-related liver disease, is expected to escalate, potentially leading to more cases of end-stage liver disease (liver failure, cirrhosis, and liver cancer). During the last 30 years, visionary governments of major nations have given clear incentives for basic/clinical research, vaccination services, and drug discovery and production in the field of hepatology.
Changing habits, such as increased alcohol intake, unhealthy diets, have increased the occurrence of liver disease. Furthermore, the increasing geriatric population has contributed to significant growth in the global demand for the treatment of liver disease. There is a significant market opportunity for this market because the prevalence of disorders has become common. Government and non-government awareness programs will contribute to the growth of the liver disease treatment industry.
Nonetheless, stringent government regulations (FDA, MHRA), high prices of drug research and development, pose a crucial challenge to the liver disease treatment industry. Side effects associated with medications are a growing concern that consumer demand is expected to decline. Patent expiry and increasing general awareness of health will promote the development of the sector. New research and technology would create an immense opportunity for market players.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited.
Strategies deployed in Liver Disease Diagnostics Market
Mar-2020: Roche announced that it received the US Food and Drug Administration (FDA) breakthrough device designation for its Elecsys GALAD score, a serum biomarker-based model. This model can predict hepatocellular carcinoma in chronic liver disease patients.
Jan-2020: Siemens launched the enhanced liver fibrosis (ELF) testing service in United States. The ELF test provides a simple, unitless numeric score via an algorithm by combining the quantitative measurements in a serum sample of three direct markers of liver fibrosis: aminoterminal propeptide of type III procollagen (PIIINP), hyaluronic acid (HA), and tissue inhibitor of metalloproteinase 1 (TIMP-1).
Nov-2019: Siemens collaborated with Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins. The collaboration was focused on nonalcoholic steatohepatitis (NASH) and liver fibrosis. This collaboration enabled Siemens Healthineers to use Galectin’s Phase 2 NASH-CX clinical trial to support regulatory filings of the ADVIA Centaur® Enhanced Liver Fibrosis (ELF) test.
Aug-2019: Boston Scientific completed the acquisition of BTG PLC, a company that develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals. The acquisition enabled it to offer best-in-class technologies, unparalleled clinical evidence and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world.
Feb-2019: Abbott got CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Determine HBsAg 2 test. This highly sensitive, easy-to-use, rapid lateral flow test enabled identification of those with the virus and facilitates linkage to care in every healthcare setting. Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV).
Dec-2017: Siemens Healthineers signed an agreement to acquire Fast Track Diagnostics (FTD), a global supplier of diagnostics tests. The acquisition would strengthen and expand its presence in the field of molecular testing and precision medicine.
Oct-2017: Abbott acquired Alere, a company that provides diagnostics and point of care solutions. The acquisition helped Abbott in becoming the global leader in point of care testing, the fastest-growing segment in vitro diagnostics market. It also strengthened the company's diagnostics presence.
Aug-2017: Abbott signed an agreement with North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust. The agreement was focused on supplying all analytical equipment and consumables. The agreement included Abbott’s Alinity ci and Alinity h series of diagnostic instruments, as well as the company’s professional services and informatics solutions known as AlinIQ.
Scope of the Study
Market Segmentation:
By End User
Liver diseases impact millions of people all over the world. In most developing nations, the prevalence of viral hepatitis is increasing as a result of modern advances in disease prevention, diagnosis, and treatment. Extended programs for systematic vaccination against the hepatitis B virus have also significantly reduced the number of new cases in many countries.
On the contrary, with better living conditions, the prevalence of the chronic liver disease, including non-alcoholic fatty liver disease and alcohol-related liver disease, is expected to escalate, potentially leading to more cases of end-stage liver disease (liver failure, cirrhosis, and liver cancer). During the last 30 years, visionary governments of major nations have given clear incentives for basic/clinical research, vaccination services, and drug discovery and production in the field of hepatology.
Changing habits, such as increased alcohol intake, unhealthy diets, have increased the occurrence of liver disease. Furthermore, the increasing geriatric population has contributed to significant growth in the global demand for the treatment of liver disease. There is a significant market opportunity for this market because the prevalence of disorders has become common. Government and non-government awareness programs will contribute to the growth of the liver disease treatment industry.
Nonetheless, stringent government regulations (FDA, MHRA), high prices of drug research and development, pose a crucial challenge to the liver disease treatment industry. Side effects associated with medications are a growing concern that consumer demand is expected to decline. Patent expiry and increasing general awareness of health will promote the development of the sector. New research and technology would create an immense opportunity for market players.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited.
Strategies deployed in Liver Disease Diagnostics Market
Mar-2020: Roche announced that it received the US Food and Drug Administration (FDA) breakthrough device designation for its Elecsys GALAD score, a serum biomarker-based model. This model can predict hepatocellular carcinoma in chronic liver disease patients.
Jan-2020: Siemens launched the enhanced liver fibrosis (ELF) testing service in United States. The ELF test provides a simple, unitless numeric score via an algorithm by combining the quantitative measurements in a serum sample of three direct markers of liver fibrosis: aminoterminal propeptide of type III procollagen (PIIINP), hyaluronic acid (HA), and tissue inhibitor of metalloproteinase 1 (TIMP-1).
Nov-2019: Siemens collaborated with Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins. The collaboration was focused on nonalcoholic steatohepatitis (NASH) and liver fibrosis. This collaboration enabled Siemens Healthineers to use Galectin’s Phase 2 NASH-CX clinical trial to support regulatory filings of the ADVIA Centaur® Enhanced Liver Fibrosis (ELF) test.
Aug-2019: Boston Scientific completed the acquisition of BTG PLC, a company that develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals. The acquisition enabled it to offer best-in-class technologies, unparalleled clinical evidence and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world.
Feb-2019: Abbott got CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Determine HBsAg 2 test. This highly sensitive, easy-to-use, rapid lateral flow test enabled identification of those with the virus and facilitates linkage to care in every healthcare setting. Hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV).
Dec-2017: Siemens Healthineers signed an agreement to acquire Fast Track Diagnostics (FTD), a global supplier of diagnostics tests. The acquisition would strengthen and expand its presence in the field of molecular testing and precision medicine.
Oct-2017: Abbott acquired Alere, a company that provides diagnostics and point of care solutions. The acquisition helped Abbott in becoming the global leader in point of care testing, the fastest-growing segment in vitro diagnostics market. It also strengthened the company's diagnostics presence.
Aug-2017: Abbott signed an agreement with North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust. The agreement was focused on supplying all analytical equipment and consumables. The agreement included Abbott’s Alinity ci and Alinity h series of diagnostic instruments, as well as the company’s professional services and informatics solutions known as AlinIQ.
Scope of the Study
Market Segmentation:
By End User
- Hospitals, Laboratories and Other End Users
- Imaging
- Biopsy
- Endoscopy
- Laboratory tests and
- Other Diagnosis Techniques
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Boston Scientific Corporation
- Siemens AG (Siemens Healthineers)
- Bayer AG
- Merck & Co., Inc.
- Sanofi S.A.
- Novartis AG
- Pfizer, Inc.
- Randox laboratories limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Liver Disease Diagnostics Market, by End User
1.4.2 Global Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 Global Liver Disease Diagnostics Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 Global Hospitals Market by Region
3.2 Global Laboratories Market by Region
3.3 Global Other End Users Market by Region
CHAPTER 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 Global Imaging Market by Region
4.2 Global Biopsy Market by Region
4.3 Global Endoscopy Market by Region
4.4 Global Laboratory tests Market by Region
4.5 Global Other Diagnosis Techniques Market by Region
CHAPTER 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION
5.1 North America Liver Disease Diagnostics Market
5.1.1 North America Liver Disease Diagnostics Market by End User
5.1.1.1 North America Hospitals Market by Country
5.1.1.2 North America Laboratories Market by Country
5.1.1.3 North America Other End Users Market by Country
5.1.2 North America Liver Disease Diagnostics Market by Diagnosis Technique
5.1.2.1 North America Imaging Market by Country
5.1.2.2 North America Biopsy Market by Country
5.1.2.3 North America Endoscopy Market by Country
5.1.2.4 North America Laboratory tests Market by Country
5.1.2.5 North America Other Diagnosis Techniques Market by Country
5.1.3 North America Liver Disease Diagnostics Market by Country
5.1.3.1 US Liver Disease Diagnostics Market
5.1.3.1.1 US Liver Disease Diagnostics Market by End User
5.1.3.1.2 US Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.2 Canada Liver Disease Diagnostics Market
5.1.3.2.1 Canada Liver Disease Diagnostics Market by End User
5.1.3.2.2 Canada Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.3 Mexico Liver Disease Diagnostics Market
5.1.3.3.1 Mexico Liver Disease Diagnostics Market by End User
5.1.3.3.2 Mexico Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.4 Rest of North America Liver Disease Diagnostics Market
5.1.3.4.1 Rest of North America Liver Disease Diagnostics Market by End User
5.1.3.4.2 Rest of North America Liver Disease Diagnostics Market by Diagnosis Technique
5.2 Europe Liver Disease Diagnostics Market
5.2.1 Europe Liver Disease Diagnostics Market by End User
5.2.1.1 Europe Hospitals Market by Country
5.2.1.2 Europe Laboratories Market by Country
5.2.1.3 Europe Other End Users Market by Country
5.2.2 Europe Liver Disease Diagnostics Market by Diagnosis Technique
5.2.2.1 Europe Imaging Market by Country
5.2.2.2 Europe Biopsy Market by Country
5.2.2.3 Europe Endoscopy Market by Country
5.2.2.4 Europe Laboratory tests Market by Country
5.2.2.5 Europe Other Diagnosis Techniques Market by Country
5.2.3 Europe Liver Disease Diagnostics Market by Country
5.2.3.1 Germany Liver Disease Diagnostics Market
5.2.3.1.1 Germany Liver Disease Diagnostics Market by End User
5.2.3.1.2 Germany Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.2 UK Liver Disease Diagnostics Market
5.2.3.2.1 UK Liver Disease Diagnostics Market by End User
5.2.3.2.2 UK Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.3 France Liver Disease Diagnostics Market
5.2.3.3.1 France Liver Disease Diagnostics Market by End User
5.2.3.3.2 France Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.4 Russia Liver Disease Diagnostics Market
5.2.3.4.1 Russia Liver Disease Diagnostics Market by End User
5.2.3.4.2 Russia Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.5 Spain Liver Disease Diagnostics Market
5.2.3.5.1 Spain Liver Disease Diagnostics Market by End User
5.2.3.5.2 Spain Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.6 Italy Liver Disease Diagnostics Market
5.2.3.6.1 Italy Liver Disease Diagnostics Market by End User
5.2.3.6.2 Italy Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.7 Rest of Europe Liver Disease Diagnostics Market
5.2.3.7.1 Rest of Europe Liver Disease Diagnostics Market by End User
5.2.3.7.2 Rest of Europe Liver Disease Diagnostics Market by Diagnosis Technique
5.3 Asia Pacific Liver Disease Diagnostics Market
5.3.1 Asia Pacific Liver Disease Diagnostics Market by End User
5.3.1.1 Asia Pacific Hospitals Market by Country
5.3.1.2 Asia Pacific Laboratories Market by Country
5.3.1.3 Asia Pacific Other End Users Market by Country
5.3.2 Asia Pacific Liver Disease Diagnostics Market by Diagnosis Technique
5.3.2.1 Asia Pacific Imaging Market by Country
5.3.2.2 Asia Pacific Biopsy Market by Country
5.3.2.3 Asia Pacific Endoscopy Market by Country
5.3.2.4 Asia Pacific Laboratory tests Market by Country
5.3.2.5 Asia Pacific Other Diagnosis Techniques Market by Country
5.3.3 Asia Pacific Liver Disease Diagnostics Market by Country
5.3.3.1 China Liver Disease Diagnostics Market
5.3.3.1.1 China Liver Disease Diagnostics Market by End User
5.3.3.1.2 China Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.2 Japan Liver Disease Diagnostics Market
5.3.3.2.1 Japan Liver Disease Diagnostics Market by End User
5.3.3.2.2 Japan Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.3 India Liver Disease Diagnostics Market
5.3.3.3.1 India Liver Disease Diagnostics Market by End User
5.3.3.3.2 India Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.4 South Korea Liver Disease Diagnostics Market
5.3.3.4.1 South Korea Liver Disease Diagnostics Market by End User
5.3.3.4.2 South Korea Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.5 Singapore Liver Disease Diagnostics Market
5.3.3.5.1 Singapore Liver Disease Diagnostics Market by End User
5.3.3.5.2 Singapore Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.6 Malaysia Liver Disease Diagnostics Market
5.3.3.6.1 Malaysia Liver Disease Diagnostics Market by End User
5.3.3.6.2 Malaysia Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.7 Rest of Asia Pacific Liver Disease Diagnostics Market
5.3.3.7.1 Rest of Asia Pacific Liver Disease Diagnostics Market by End User
5.3.3.7.2 Rest of Asia Pacific Liver Disease Diagnostics Market by Diagnosis Technique
5.4 LAMEA Liver Disease Diagnostics Market
5.4.1 LAMEA Liver Disease Diagnostics Market by End User
5.4.1.1 LAMEA Hospitals Market by Country
5.4.1.2 LAMEA Laboratories Market by Country
5.4.1.3 LAMEA Other End Users Market by Country
5.4.2 LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
5.4.2.1 LAMEA Imaging Market by Country
5.4.2.2 LAMEA Biopsy Market by Country
5.4.2.3 LAMEA Endoscopy Market by Country
5.4.2.4 LAMEA Laboratory tests Market by Country
5.4.2.5 LAMEA Other Diagnosis Techniques Market by Country
5.4.3 LAMEA Liver Disease Diagnostics Market by Country
5.4.3.1 Brazil Liver Disease Diagnostics Market
5.4.3.1.1 Brazil Liver Disease Diagnostics Market by End User
5.4.3.1.2 Brazil Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.2 Argentina Liver Disease Diagnostics Market
5.4.3.2.1 Argentina Liver Disease Diagnostics Market by End User
5.4.3.2.2 Argentina Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.3 UAE Liver Disease Diagnostics Market
5.4.3.3.1 UAE Liver Disease Diagnostics Market by End User
5.4.3.3.2 UAE Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.4 Saudi Arabia Liver Disease Diagnostics Market
5.4.3.4.1 Saudi Arabia Liver Disease Diagnostics Market by End User
5.4.3.4.2 Saudi Arabia Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.5 South Africa Liver Disease Diagnostics Market
5.4.3.5.1 South Africa Liver Disease Diagnostics Market by End User
5.4.3.5.2 South Africa Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.6 Nigeria Liver Disease Diagnostics Market
5.4.3.6.1 Nigeria Liver Disease Diagnostics Market by End User
5.4.3.6.2 Nigeria Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.7 Rest of LAMEA Liver Disease Diagnostics Market
5.4.3.7.1 Rest of LAMEA Liver Disease Diagnostics Market by End User
5.4.3.7.2 Rest of LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Liver Disease Diagnostics Market, by End User
1.4.2 Global Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 Global Liver Disease Diagnostics Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 Global Hospitals Market by Region
3.2 Global Laboratories Market by Region
3.3 Global Other End Users Market by Region
CHAPTER 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 Global Imaging Market by Region
4.2 Global Biopsy Market by Region
4.3 Global Endoscopy Market by Region
4.4 Global Laboratory tests Market by Region
4.5 Global Other Diagnosis Techniques Market by Region
CHAPTER 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION
5.1 North America Liver Disease Diagnostics Market
5.1.1 North America Liver Disease Diagnostics Market by End User
5.1.1.1 North America Hospitals Market by Country
5.1.1.2 North America Laboratories Market by Country
5.1.1.3 North America Other End Users Market by Country
5.1.2 North America Liver Disease Diagnostics Market by Diagnosis Technique
5.1.2.1 North America Imaging Market by Country
5.1.2.2 North America Biopsy Market by Country
5.1.2.3 North America Endoscopy Market by Country
5.1.2.4 North America Laboratory tests Market by Country
5.1.2.5 North America Other Diagnosis Techniques Market by Country
5.1.3 North America Liver Disease Diagnostics Market by Country
5.1.3.1 US Liver Disease Diagnostics Market
5.1.3.1.1 US Liver Disease Diagnostics Market by End User
5.1.3.1.2 US Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.2 Canada Liver Disease Diagnostics Market
5.1.3.2.1 Canada Liver Disease Diagnostics Market by End User
5.1.3.2.2 Canada Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.3 Mexico Liver Disease Diagnostics Market
5.1.3.3.1 Mexico Liver Disease Diagnostics Market by End User
5.1.3.3.2 Mexico Liver Disease Diagnostics Market by Diagnosis Technique
5.1.3.4 Rest of North America Liver Disease Diagnostics Market
5.1.3.4.1 Rest of North America Liver Disease Diagnostics Market by End User
5.1.3.4.2 Rest of North America Liver Disease Diagnostics Market by Diagnosis Technique
5.2 Europe Liver Disease Diagnostics Market
5.2.1 Europe Liver Disease Diagnostics Market by End User
5.2.1.1 Europe Hospitals Market by Country
5.2.1.2 Europe Laboratories Market by Country
5.2.1.3 Europe Other End Users Market by Country
5.2.2 Europe Liver Disease Diagnostics Market by Diagnosis Technique
5.2.2.1 Europe Imaging Market by Country
5.2.2.2 Europe Biopsy Market by Country
5.2.2.3 Europe Endoscopy Market by Country
5.2.2.4 Europe Laboratory tests Market by Country
5.2.2.5 Europe Other Diagnosis Techniques Market by Country
5.2.3 Europe Liver Disease Diagnostics Market by Country
5.2.3.1 Germany Liver Disease Diagnostics Market
5.2.3.1.1 Germany Liver Disease Diagnostics Market by End User
5.2.3.1.2 Germany Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.2 UK Liver Disease Diagnostics Market
5.2.3.2.1 UK Liver Disease Diagnostics Market by End User
5.2.3.2.2 UK Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.3 France Liver Disease Diagnostics Market
5.2.3.3.1 France Liver Disease Diagnostics Market by End User
5.2.3.3.2 France Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.4 Russia Liver Disease Diagnostics Market
5.2.3.4.1 Russia Liver Disease Diagnostics Market by End User
5.2.3.4.2 Russia Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.5 Spain Liver Disease Diagnostics Market
5.2.3.5.1 Spain Liver Disease Diagnostics Market by End User
5.2.3.5.2 Spain Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.6 Italy Liver Disease Diagnostics Market
5.2.3.6.1 Italy Liver Disease Diagnostics Market by End User
5.2.3.6.2 Italy Liver Disease Diagnostics Market by Diagnosis Technique
5.2.3.7 Rest of Europe Liver Disease Diagnostics Market
5.2.3.7.1 Rest of Europe Liver Disease Diagnostics Market by End User
5.2.3.7.2 Rest of Europe Liver Disease Diagnostics Market by Diagnosis Technique
5.3 Asia Pacific Liver Disease Diagnostics Market
5.3.1 Asia Pacific Liver Disease Diagnostics Market by End User
5.3.1.1 Asia Pacific Hospitals Market by Country
5.3.1.2 Asia Pacific Laboratories Market by Country
5.3.1.3 Asia Pacific Other End Users Market by Country
5.3.2 Asia Pacific Liver Disease Diagnostics Market by Diagnosis Technique
5.3.2.1 Asia Pacific Imaging Market by Country
5.3.2.2 Asia Pacific Biopsy Market by Country
5.3.2.3 Asia Pacific Endoscopy Market by Country
5.3.2.4 Asia Pacific Laboratory tests Market by Country
5.3.2.5 Asia Pacific Other Diagnosis Techniques Market by Country
5.3.3 Asia Pacific Liver Disease Diagnostics Market by Country
5.3.3.1 China Liver Disease Diagnostics Market
5.3.3.1.1 China Liver Disease Diagnostics Market by End User
5.3.3.1.2 China Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.2 Japan Liver Disease Diagnostics Market
5.3.3.2.1 Japan Liver Disease Diagnostics Market by End User
5.3.3.2.2 Japan Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.3 India Liver Disease Diagnostics Market
5.3.3.3.1 India Liver Disease Diagnostics Market by End User
5.3.3.3.2 India Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.4 South Korea Liver Disease Diagnostics Market
5.3.3.4.1 South Korea Liver Disease Diagnostics Market by End User
5.3.3.4.2 South Korea Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.5 Singapore Liver Disease Diagnostics Market
5.3.3.5.1 Singapore Liver Disease Diagnostics Market by End User
5.3.3.5.2 Singapore Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.6 Malaysia Liver Disease Diagnostics Market
5.3.3.6.1 Malaysia Liver Disease Diagnostics Market by End User
5.3.3.6.2 Malaysia Liver Disease Diagnostics Market by Diagnosis Technique
5.3.3.7 Rest of Asia Pacific Liver Disease Diagnostics Market
5.3.3.7.1 Rest of Asia Pacific Liver Disease Diagnostics Market by End User
5.3.3.7.2 Rest of Asia Pacific Liver Disease Diagnostics Market by Diagnosis Technique
5.4 LAMEA Liver Disease Diagnostics Market
5.4.1 LAMEA Liver Disease Diagnostics Market by End User
5.4.1.1 LAMEA Hospitals Market by Country
5.4.1.2 LAMEA Laboratories Market by Country
5.4.1.3 LAMEA Other End Users Market by Country
5.4.2 LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
5.4.2.1 LAMEA Imaging Market by Country
5.4.2.2 LAMEA Biopsy Market by Country
5.4.2.3 LAMEA Endoscopy Market by Country
5.4.2.4 LAMEA Laboratory tests Market by Country
5.4.2.5 LAMEA Other Diagnosis Techniques Market by Country
5.4.3 LAMEA Liver Disease Diagnostics Market by Country
5.4.3.1 Brazil Liver Disease Diagnostics Market
5.4.3.1.1 Brazil Liver Disease Diagnostics Market by End User
5.4.3.1.2 Brazil Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.2 Argentina Liver Disease Diagnostics Market
5.4.3.2.1 Argentina Liver Disease Diagnostics Market by End User
5.4.3.2.2 Argentina Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.3 UAE Liver Disease Diagnostics Market
5.4.3.3.1 UAE Liver Disease Diagnostics Market by End User
5.4.3.3.2 UAE Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.4 Saudi Arabia Liver Disease Diagnostics Market
5.4.3.4.1 Saudi Arabia Liver Disease Diagnostics Market by End User
5.4.3.4.2 Saudi Arabia Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.5 South Africa Liver Disease Diagnostics Market
5.4.3.5.1 South Africa Liver Disease Diagnostics Market by End User
5.4.3.5.2 South Africa Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.6 Nigeria Liver Disease Diagnostics Market
5.4.3.6.1 Nigeria Liver Disease Diagnostics Market by End User
5.4.3.6.2 Nigeria Liver Disease Diagnostics Market by Diagnosis Technique
5.4.3.7 Rest of LAMEA Liver Disease Diagnostics Market
5.4.3.7.1 Rest of LAMEA Liver Disease Diagnostics Market by End User
5.4.3.7.2 Rest of LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 2 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 3 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 4 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 5 GLOBAL HOSPITALS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 6 GLOBAL HOSPITALS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 7 GLOBAL LABORATORIES MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 8 GLOBAL LABORATORIES MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 9 GLOBAL OTHER END USERS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 10 GLOBAL OTHER END USERS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 11 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 12 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 13 GLOBAL IMAGING MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 14 GLOBAL IMAGING MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 15 GLOBAL BIOPSY MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 16 GLOBAL BIOPSY MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 17 GLOBAL ENDOSCOPY MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 18 GLOBAL ENDOSCOPY MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 19 GLOBAL LABORATORY TESTS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 20 GLOBAL LABORATORY TESTS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 21 GLOBAL OTHER DIAGNOSIS TECHNIQUES MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 22 GLOBAL OTHER DIAGNOSIS TECHNIQUES MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 23 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 24 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 25 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 26 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 27 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 28 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 29 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 30 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 31 NORTH AMERICA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 32 NORTH AMERICA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 33 NORTH AMERICA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 34 NORTH AMERICA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 35 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 36 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 37 NORTH AMERICA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 38 NORTH AMERICA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 39 NORTH AMERICA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 40 NORTH AMERICA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 41 NORTH AMERICA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 42 NORTH AMERICA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 43 NORTH AMERICA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 44 NORTH AMERICA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 45 NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 46 NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 47 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 48 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 49 US LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 50 US LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 51 US LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 52 US LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 53 US LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 54 US LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 55 CANADA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 56 CANADA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 57 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 58 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 59 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 60 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 61 MEXICO LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 62 MEXICO LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 63 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 64 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 65 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 66 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 67 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 68 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 69 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 70 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 71 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 72 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 73 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 74 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 75 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 76 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 77 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 78 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 79 EUROPE LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 80 EUROPE LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 81 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 82 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 83 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 84 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 85 EUROPE IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 86 EUROPE IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 87 EUROPE BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 88 EUROPE BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 89 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 90 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 91 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 92 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 93 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 94 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 95 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 96 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 97 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 98 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 99 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 100 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 101 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 102 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 103 UK LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 104 UK LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 105 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 106 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 107 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 108 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 109 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 110 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 111 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 112 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 113 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 114 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 115 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 116 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 117 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 118 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 119 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 120 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 121 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 122 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 123 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 124 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 125 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 126 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 127 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 128 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 129 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 130 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 131 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 132 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 133 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 134 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 135 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 136 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 137 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 138 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 139 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 140 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 141 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 142 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 143 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 144 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 145 ASIA PACIFIC LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 146 ASIA PACIFIC LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 147 ASIA PACIFIC OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 148 ASIA PACIFIC OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 149 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 150 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 151 ASIA PACIFIC IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 152 ASIA PACIFIC IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 153 ASIA PACIFIC BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 154 ASIA PACIFIC BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 155 ASIA PACIFIC ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 156 ASIA PACIFIC ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 157 ASIA PACIFIC LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 158 ASIA PACIFIC LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 159 ASIA PACIFIC OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 160 ASIA PACIFIC OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 161 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 162 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 163 CHINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 164 CHINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 165 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 166 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 167 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 168 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 169 JAPAN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 170 JAPAN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 171 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 172 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 173 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 174 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 175 INDIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 176 INDIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 177 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 178 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 179 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 180 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 181 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 182 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 183 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 184 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 185 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 186 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 187 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 188 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 189 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 190 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 191 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 192 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 193 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 194 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 195 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 196 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 197 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 198 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 199 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 200 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 201 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 202 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 203 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 204 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 205 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 206 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 207 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 208 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 209 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 210 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 211 LAMEA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 212 LAMEA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 213 LAMEA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 214 LAMEA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 215 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 216 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 217 LAMEA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 218 LAMEA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 219 LAMEA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 220 LAMEA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 221 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 222 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 223 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 224 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 225 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 226 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 227 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 228 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 229 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 230 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 231 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 232 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 233 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 234 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 235 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 236 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 237 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 238 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 239 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 240 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 241 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 242 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 243 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 244 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 245 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 246 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 247 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 248 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 249 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 250 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 251 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 252 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 253 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 254 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 255 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 256 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 257 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 258 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 259 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 260 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 261 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 262 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 263 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 264 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 265 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 266 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 267 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 268 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 269 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 270 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 271 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 272 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 273 KEY INFORMATION – SIEMENS AG
TABLE 274 KEY INFORMATION – BAYER AG
TABLE 275 KEY INFORMATION - MERCK & CO., INC.
TABLE 276 KEY INFORMATION – SANOFI S.A.
TABLE 277 KEY INFORMATION – NOVARTIS AG
TABLE 278 KEY INFORMATION – PFIZER, INC.
TABLE 279 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 1 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 2 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 3 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 4 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 5 GLOBAL HOSPITALS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 6 GLOBAL HOSPITALS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 7 GLOBAL LABORATORIES MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 8 GLOBAL LABORATORIES MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 9 GLOBAL OTHER END USERS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 10 GLOBAL OTHER END USERS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 11 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 12 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 13 GLOBAL IMAGING MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 14 GLOBAL IMAGING MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 15 GLOBAL BIOPSY MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 16 GLOBAL BIOPSY MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 17 GLOBAL ENDOSCOPY MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 18 GLOBAL ENDOSCOPY MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 19 GLOBAL LABORATORY TESTS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 20 GLOBAL LABORATORY TESTS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 21 GLOBAL OTHER DIAGNOSIS TECHNIQUES MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 22 GLOBAL OTHER DIAGNOSIS TECHNIQUES MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 23 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION, 2016 - 2019, USD MILLIONS
TABLE 24 GLOBAL LIVER DISEASE DIAGNOSTICS MARKET BY REGION, 2020 - 2026, USD MILLIONS
TABLE 25 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 26 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 27 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 28 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 29 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 30 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 31 NORTH AMERICA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 32 NORTH AMERICA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 33 NORTH AMERICA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 34 NORTH AMERICA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 35 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 36 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 37 NORTH AMERICA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 38 NORTH AMERICA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 39 NORTH AMERICA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 40 NORTH AMERICA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 41 NORTH AMERICA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 42 NORTH AMERICA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 43 NORTH AMERICA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 44 NORTH AMERICA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 45 NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 46 NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 47 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 48 NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 49 US LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 50 US LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 51 US LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 52 US LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 53 US LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 54 US LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 55 CANADA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 56 CANADA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 57 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 58 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 59 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 60 CANADA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 61 MEXICO LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 62 MEXICO LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 63 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 64 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 65 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 66 MEXICO LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 67 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 68 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 69 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 70 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 71 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 72 REST OF NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 73 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 74 EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 75 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 76 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 77 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 78 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 79 EUROPE LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 80 EUROPE LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 81 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 82 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 83 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 84 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 85 EUROPE IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 86 EUROPE IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 87 EUROPE BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 88 EUROPE BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 89 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 90 EUROPE ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 91 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 92 EUROPE LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 93 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 94 EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 95 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 96 EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 97 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 98 GERMANY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 99 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 100 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 101 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 102 GERMANY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 103 UK LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 104 UK LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 105 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 106 UK LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 107 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 108 UK LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 109 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 110 FRANCE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 111 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 112 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 113 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 114 FRANCE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 115 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 116 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 117 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 118 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 119 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 120 RUSSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 121 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 122 SPAIN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 123 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 124 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 125 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 126 SPAIN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 127 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 128 ITALY LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 129 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 130 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 131 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 132 ITALY LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 133 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 134 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 135 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 136 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 137 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 138 REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 139 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 140 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 141 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 142 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 143 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 144 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 145 ASIA PACIFIC LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 146 ASIA PACIFIC LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 147 ASIA PACIFIC OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 148 ASIA PACIFIC OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 149 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 150 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 151 ASIA PACIFIC IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 152 ASIA PACIFIC IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 153 ASIA PACIFIC BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 154 ASIA PACIFIC BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 155 ASIA PACIFIC ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 156 ASIA PACIFIC ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 157 ASIA PACIFIC LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 158 ASIA PACIFIC LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 159 ASIA PACIFIC OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 160 ASIA PACIFIC OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 161 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 162 ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 163 CHINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 164 CHINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 165 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 166 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 167 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 168 CHINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 169 JAPAN LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 170 JAPAN LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 171 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 172 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 173 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 174 JAPAN LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 175 INDIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 176 INDIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 177 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 178 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 179 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 180 INDIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 181 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 182 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 183 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 184 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 185 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 186 SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 187 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 188 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 189 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 190 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 191 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 192 SINGAPORE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 193 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 194 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 195 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 196 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 197 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 198 MALAYSIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 199 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 200 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 201 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 202 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 203 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 204 REST OF ASIA PACIFIC LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 205 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 206 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 207 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 208 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 209 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 210 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 211 LAMEA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 212 LAMEA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 213 LAMEA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 214 LAMEA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 215 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 216 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 217 LAMEA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 218 LAMEA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 219 LAMEA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 220 LAMEA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 221 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 222 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 223 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 224 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 225 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 226 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 227 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLIONS
TABLE 228 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLIONS
TABLE 229 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 230 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 231 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 232 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 233 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 234 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 235 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 236 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 237 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 238 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 239 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 240 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 241 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 242 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 243 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 244 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 245 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 246 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 247 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 248 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 249 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 250 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 251 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 252 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 253 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 254 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 255 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 256 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 257 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 258 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 259 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 260 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 261 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 262 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 263 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 264 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLIONS
TABLE 265 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLIONS
TABLE 266 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLIONS
TABLE 267 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLIONS
TABLE 268 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLIONS
TABLE 269 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLIONS
TABLE 270 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 271 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 272 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 273 KEY INFORMATION – SIEMENS AG
TABLE 274 KEY INFORMATION – BAYER AG
TABLE 275 KEY INFORMATION - MERCK & CO., INC.
TABLE 276 KEY INFORMATION – SANOFI S.A.
TABLE 277 KEY INFORMATION – NOVARTIS AG
TABLE 278 KEY INFORMATION – PFIZER, INC.
TABLE 279 KEY INFORMATION – RANDOX LABORATORIES LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
